178
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 2981-2990 | Published online: 18 Oct 2019

References

  • Lopes SL, Ferreira AI, Passos AM, Neves M, Sousa C, Sa MJ. Depressive symptomatology, presenteeism productivity, and quality of life: a moderated mediation model. J Occup Environ Med. 2018;60:301–308. doi:10.1097/JOM.000000000000125329252917
  • Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study. Neuropsychiatr Dis Treat. 2018;14:1339–1350. doi:10.2147/NDT.S15927629872301
  • Sumiyoshi T, Watanabe K, Noto S, et al. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: cross-sectional analysis of baseline data from PERFORM-J. J Affect Disord. 2019;258:172–178. doi:10.1016/j.jad.2019.07.06431426015
  • Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi:10.1016/S0140-6736(15)00241-X26388529
  • American Psychiatric Association. Diagnostic and Statistical Manual of Psychiatric Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  • Morton E, Murray G, Michalak EE, et al. Quality of life in bipolar disorder: towards a dynamic understanding. Psychol Med. 2018;48(7):1111–1118. doi:10.1017/S003329171700249528918761
  • Harrison PJ, Geddes JR, Tunbridge EM. The emerging neurobiology of bipolar disorder. Trends Neurosci. 2018;41(1):18–30. doi:10.1016/j.tins.2017.10.00629169634
  • Martínez-Arán A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–232. doi:10.1111/j.1399-5618.2004.00111.x15117401
  • Lima FM, Cardoso TA, Serafim SD, et al. Validity and reliability of the Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) in Brazilian bipolar patients. Trends Psychiatry Psychother. 2018;40(2):170–178. doi:10.1590/2237-6089-2017-012129995161
  • Jensen JH, Støttrup MM, Nayberg E, et al. Optimising screening for cognitive dysfunction in bipolar disorder: validation and evaluation of objective and subjective tools. J Affect Disord. 2015;187:10–19. doi:10.1016/j.jad.2015.07.03926301477
  • Demant KM, Vinberg M, Kessing LV, Miskowiak KW. Assessment of subjective and objective cognitive function in bipolar disorder: correlations, predictors and the relation to psychosocial function. Psychiatry Res. 2015;229(1–2):565–571. doi:10.1016/j.psychres.2015.05.02226073281
  • Sumiyoshi T, Toyomaki A, Kawano N, et al. Verbal memory impairment in patients with subsyndromal bipolar disorder. Front Psychiatry. 2017;8:168. doi:10.3389/fpsyt.2017.0029728966598
  • Vieta E, Berk M, Schulze TG, et al. Bipolar disorders. Nat Rev Dis Primers. 2018;4:18008. doi:10.1038/nrdp.2018.829516993
  • Rosa AR, Mercadé C, Sánchez-Moreno J, et al. Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA). J Affect Disord. 2013;150(1):29–36. doi:10.1016/j.jad.2013.02.02223497792
  • Miskowiak KW, Burdick KE, Martinez-Aran A, et al. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disord. 2018;20(3):184–194. doi:10.1111/bdi.1259529345040
  • Toyoshima K, Fujii Y, Mitsui N, et al. Validity and reliability of the Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) in Japanese patients with bipolar disorder. Psychiatry Res. 2017;254:85–89. doi:10.1016/j.psychres.2017.04.04328457989
  • Toyoshima K, Kako Y, Toyomaki A, et al. Associations between cognitive impairment and quality of life in euthymic bipolar patients. Psychiatry Res. 2019;271:510–515. doi:10.1016/j.psychres.2018.11.06130551083
  • Ware JE, Kosinski M, Dewey JE, Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Lincoln, RI: QualityMetric, Inc.; Boston, MA: Health Assessment Lab; 2001.
  • Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–1044. doi:10.1016/s0895-4356(98)00095-x9817121
  • Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol. 1998;51(11):1045–1053. doi:10.1016/s0895-4356(98)00096-19817122
  • Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95. doi:10.1097/00004850-199606003-00015
  • Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in QoL and quality of sleep. J Affect Disord. 2008;111(2–3):306–319. doi:10.1016/j.jad.2008.06.01918774180
  • Arbuckle R, Frye MA, Brecher M, et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res. 2009;165(1–2):163–174. doi:10.1016/j.psychres.2007.11.01819042030
  • Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. Int Clin Psychopharmacol. 2011;26(2):75–83. doi:10.1097/YIC.0b013e328341bb5f21102344
  • Leon AC, Olfson M, Portera L, Farber L, Sheehan DV. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med. 1997;27(2):93–105. doi:10.2190/T8EM-C8YH-373N-1UWD9565717
  • Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation Of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–1744. doi:10.1001/jama.282.18.173710568646
  • Muramatsu K, Miyaoka H, Kamijima K, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep. 2007;101(3 Pt 1):952–960. doi:10.2466/pr0.101.3.952-96018232454
  • Muramatsu K, Miyaoka H, Kamijima K, et al. Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. Gen Hosp Psychiatry. 2018;52:64–69. doi:10.1016/j.genhosppsych.2018.03.00729698880
  • Shimizu Y, Kitagawa N, Mitsui N, et al. Neurocognitive impairments and quality of life in unemployed patients with remitted major depressive disorder. Psychiatry Res. 2013;210(3):913–918. doi:10.1016/j.psychres.2013.08.03024041752
  • Xiao L, Gao Y, Zhang L, Chen P, Sun X. The relationship between cognitive function and quality of life in euthymic Chinese patients with bipolar disorder. Psychiatry Res. 2016;246:427–431. doi:10.1016/j.psychres.2016.10.02627788464
  • Tatay-Manteiga A, Cauli O, Tabarés-Seisdedos R, Michalak EE, Kapczinski F, Balanzá-Martínez V. Subjective neurocognition and quality of life in patients with bipolar disorder and siblings. J Affect Disord. 2019;245:283–288. doi:10.1016/j.jad.2018.11.01230419528
  • Martínez-Arán A, Vieta E, Colom F, et al. Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom. 2005;74(5):295–302. doi:10.1159/00008632016088267
  • Lin X, Lu D, Huang Z, Chen W, Luo X, Zhu Y. The associations between subjective and objective cognitive functioning across manic or hypomanic, depressed, and euthymic states in Chinese bipolar patients. J Affect Disord. 2019;249:73–81. doi:10.1016/j.jad.2019.02.02530763798
  • Fava GA, Carrozzino D, Lindberg L, Tomba E. The clinimetric approach to psychological assessment: a tribute to per bech, MD (1942–2018). Psychother Psychosom. 2018;87(6):321–326. doi:10.1159/00049374630269137
  • Carrozzino D. Clinimetric approach to rating scales for the assessment of apathy in Parkinson’s disease: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;2019(94):109641. doi:10.1016/j.pnpbp.2019.109641
  • Carrozzino D, Svicher A, Patierno C, Berrocal C, Cosci F. The euthymia scale: a clinimetric analysis. Psychother Psychosom. 2019;88(2):119–121. doi:10.1159/00049623030699426